Advertisement

Immune and Endocrine Function in Child and Adolescent Obsessive Compulsive Disorder

  • Tanya K. Murphy
  • Kelley Yokum
Chapter

Abstract

Dr. Laurence Selling made one of the earliest reported cases of this potential correlation between the onset of tics and infectious disease in 1929 when he described three cases of tics associated with sinusitis (Selling, 1929). Subsequently, psychoanalytic theories prevailed in etiologic theories of Tourette Syndrome (TS) (Kushner & Kiessling, 1996). Just before the “medicalization” of (TS) in 1965, Langlois and Force described a 6-year-old child with TS and Sydenham chorea (SC) symptoms following several infectious illnesses that were successfully treated with antibiotics and neuroleptics (Langlois & Force, 1965). They argued that Tourette was wrong to say TS was incurable and separate from SC, but that TS should be viewed as sequel to acute chorea. After a lag of approximately 20 years, the argument reappeared that, in at least some cases, tics and obsessive compulsive disorder (OCD) are related to infectious processes. In the late 1980s, researchers noted that patients with SC often developed OCD symptoms, and further inquiry found that patients with SC often had tics as well. Additional investigation found that some patients with Group A Streptococcus (GAS) infections, but without the neurological findings of SC, also presented with OCD symptoms (Allen, Leonard, & Swedo, 1995; Swedo & Leonard, 1994). Similarly, around this same time, Louise Kiessling and colleagues reported on the association of tics during GAS outbreaks as seen in a developmental pediatric practice (Kiessling, Marcotte, & Culpepper, 1993). The first case report (Allen et al., 1995) detailed four children who presented with sudden onset or worsening of OCD and/or tics following an infection (2 viral, 2 GAS). Subsequently in 1998, based on these observations and reports, a group from the National Institute of Mental Health further characterized (in a 50 patient case series) an entity they called “pediatric autoimmune neuropsychiatric disorders associated with streptococcus” (PANDAS). Careful reading of these case series suggests that GAS is the inciting trigger, but future exacerbations are activated not only by GAS infection but GAS exposure and viral illness as well.

Keywords

Obsessive Compulsive Disorder Tourette Syndrome Rheumatic Fever Corticotrophin Release Factor Necrotizing Fasciitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ahmed, N. (2005). Twenty-three years of the discovery of Helicobacter pylori: Is the debate over? Annals of Clinical Microbiology and Antimicrobials, 4, 17.PubMedGoogle Scholar
  2. Allen, A. J., Leonard, H. L., & Swedo, S. E. (1995). Case study: A new infection-triggered, autoimmune subtype of pediatric OCD and Tourette’s syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 307–311.PubMedGoogle Scholar
  3. Atmaca, M., Yildirim, H., Ozler, S., Koc, M., Kara, B., & Sec, S. (2009). Smaller pituitary volume in adult patients with obsessive-compulsive disorder. Psychiatry and Clinical Neurosciences, 63, 516–520.PubMedGoogle Scholar
  4. Ayoub, E. M. (1992). Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness. Postgraduate Medicine, 92(133–136), 139–142.Google Scholar
  5. Benatar, A., Beatty, D. W., & Human, D. G. (1988). Immunological abnormalities in children with acute rheumatic carditis and acute post-streptococcal glomerulonephritis. International Journal of Cardiology, 21, 51–58.PubMedGoogle Scholar
  6. Berrios, X., Quesney, F., Morales, A., Blazquez, J., & Bisno, A. L. (1985). Are all recurrences of “pure” Sydenham chorea true recurrences of acute rheumatic fever? Jornal de Pediatria, 107(6), 867–872.Google Scholar
  7. Bisno, A. L., Brito, M. O., & Collins, C. M. (2003). Molecular basis of group A streptococcal virulence. The Lancet Infectious Diseases, 3, 191–200.PubMedGoogle Scholar
  8. Black, J. L., Lamke, G. T., & Walikonis, J. E. (1998). Serologic survey of adult patients with obsessive-compulsive disorder for neuron-specific and other autoantibodies. Psychiatry Research, 81, 371–380.PubMedGoogle Scholar
  9. Bloch, M. H., Peterson, B. S., Scahill, L., Otka, J., Katsovich, L., Zhang, H., et al. (2006). Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Archives of Pediatrics & Adolescent Medicine, 160, 65–69.Google Scholar
  10. Bloem, A. C., Jurgens, R., Eichmann, K., & Emmrich, F. (1988). Human immune response to group A streptococcal carbohydrate (A-CHO). III. Comparison of the efficiencies of anti-idiotopic antibody and of nominal antigen in the induction of IgM anti-A-CHO-­producing B cells. European Journal of Immunology, 18, 1959–1964.PubMedGoogle Scholar
  11. Bombaci, M., Grifantini, R., Mora, M., Reguzzi, V., Petracca, R., Meoni, E., et al. (2009). Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against group A streptococcus antigens. PLoS ONE, 4, e6332.PubMedGoogle Scholar
  12. Brooks, B. M., Hart, C. A., & Coleman, J. W. (2005). Differential effects of beta-lactams on human IFN-gamma activity. The Journal of Antimicrobial Chemotherapy, 56, 1122–1125.PubMedGoogle Scholar
  13. Brooks, B. M., Thomas, A. L., & Coleman, J. W. (2003). Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity. Clinical and Experimental Immunology, 131(2), 268–274.PubMedGoogle Scholar
  14. Budman, C., Coffey, B., Dure, L., Gilbert, D., Juncos, J., Kaplan, E., et al. (2005). Regarding “antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders”. Biological Psychiatry, 58, 917; author reply 918–919.Google Scholar
  15. Budman, C. L., Kerjakovic, M., & Bruun, R. D. (1997). Viral infection and tic exacerbation. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 162.PubMedGoogle Scholar
  16. Cardona, F., & Orefici, G. (2001). Group A streptococcal infections and tic disorders in an Italian pediatric population. Jornal de Pediatria, 138, 71–75.Google Scholar
  17. Cardona, F., Romano, A., Cundari, G., Ventriglia, F., Versacci, P., & Orefici, G. (2004). Colour Doppler echocardiography in children with group A streptococcal infection related tic disorders. The Indian Journal of Medical Research, 119(Suppl), 186–190.PubMedGoogle Scholar
  18. Carpenter, L. L., Heninger, G. R., McDougle, C. J., Tyrka, A. R., Epperson, C. N., & Price, L. H. (2002). Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Research, 112, 257–262.PubMedGoogle Scholar
  19. Catapano, F., Monteleone, P., Maj, M., & Kemali, D. (1990). Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology, 23, 53–56.PubMedGoogle Scholar
  20. Chapman, F., Visvanathan, K., Carreno-Manjarrez, R., & Zabriskie, J. B. (1998). A flow cytometric assay for D8/17 B cell marker in patients with Tourette’s syndrome and obsessive compulsive disorder. Journal of Immunology Methods, 219(1-2), 181–186.PubMedGoogle Scholar
  21. Church, A. J., Cardoso, F., Dale, R. C., Lees, A. J., Thompson, E. J., & Giovannoni, G. (2002). Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology, 59, 227–231.PubMedGoogle Scholar
  22. Church, A. J., & Dale, R. C. (2002). Antistreptolysin-O titers: Implications for adult PANDAS. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. The American Journal of Psychiatry, 159, 320.PubMedGoogle Scholar
  23. Church, A. J., Dale, R. C., Lees, A. J., Giovannoni, G., & Robertson, M. M. (2003). Tourette’s syndrome: A cross sectional study to examine the PANDAS hypothesis. Journal of Neurology, Neurosurgery and Psychiatry, 74, 602–607.Google Scholar
  24. Coryell, W. H., Black, D. W., Kelly, M. W., & Noyes, R., Jr. (1989). HPA axis disturbance in obsessive-compulsive disorder. Psychiatry Research, 30, 243–251.PubMedGoogle Scholar
  25. Cottraux, J. A., Bouvard, M., Claustrat, B., & Juenet, C. (1984). Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: A confirmatory report. Psychiatry Research, 13, 157–165.PubMedGoogle Scholar
  26. Dale, R. C., Church, A. J., Cardoso, F., Goddard, E., Cox, T. C., Chong, W. K., et al. (2001). Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Annals of Neurology, 50, 588–595.PubMedGoogle Scholar
  27. Dale, R. C., Heyman, I., Giovannoni, G., & Church, A. W. (2005). Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. The British Journal of Psychiatry, 187, 314–319.PubMedGoogle Scholar
  28. Denys, D., Fluitman, S., Kavelaars, A., Heijnen, C., & Westenberg, H. (2004). Decreased TNF-alpha and NK activity in obsessive-compulsive disorder. Psycho­neuroendocrinology, 29, 945–952.PubMedGoogle Scholar
  29. DiFazio, M. P., Morales, J., & Davis, R. (1998). Acute myoclonus secondary to group A beta-hemolytic streptococcus infection: A PANDAS variant. Journal of Child Neurology, 13(10), 516–518.PubMedGoogle Scholar
  30. Dranitzki, Z., & Steiner, I. (2007). PANDAS in siblings: A common risk? European Journal of Neurology, 14, e4.PubMedGoogle Scholar
  31. Efstratiou, A. (2000). Group A streptococci in the 1990s. The Journal of Antimicrobial Chemotherapy, 45 Suppl, 3–12.PubMedGoogle Scholar
  32. Eisen, J. L., Leonard, H. L., Swedo, S. E., Price, L. H., Zabriskie, J. B., Chiang, S. Y., et al. (2001). The use of antibody D8/17 to identify B cells in adults with obsessive-compulsive disorder. Psychiatry Research, 104(3), 221–225.PubMedGoogle Scholar
  33. Elia, J., Dell, M. L., Friedman, D. F., Zimmerman, R. A., Balamuth, N., Ahmed, A. A., et al. (2005). PANDAS with catatonia: A case report. Therapeutic response to lorazepam and plasmapheresis. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1145–1150.PubMedGoogle Scholar
  34. Gabbay, V., Klein, R. G., Alonso, C. M., Babb, J. S., Nishawala, M., De Jesus, G., et al. (2009). Immune system dysregulation in adolescent major depressive disorder. Journal of Affective Disorders, 115, 177–182.PubMedGoogle Scholar
  35. Garvey, M. A., Perlmutter, S. J., Allen, A. J., Hamburger, S., Lougee, L., Leonard, H. L., et al. (1999). A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biological Psychiatry, 45, 1564–1571.PubMedGoogle Scholar
  36. Gebremariam, A. (1999). Sydenham’s chorea: Risk factors and the role of prophylactic benzathine penicillin G in preventing recurrence. Annals of Tropical Paediatrics, 19, 161–165.PubMedGoogle Scholar
  37. Giedd, J. N., Rapoport, J. L., Garvey, M. A., Perlmutter, S., & Swedo, S. E. (2000). MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. The American Journal of Psychiatry, 157, 281–283.PubMedGoogle Scholar
  38. Giedd, J. N., Rapoport, J. L., Leonard, H. L., Richter, D., & Swedo, S. E. (1996). Case study: Acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 913–915.PubMedGoogle Scholar
  39. Gilbert, D., & Gerber, M. A. (2005). Regarding “antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders”. Biological Psychiatry, 58, 916.PubMedGoogle Scholar
  40. Giulino, L., Gammon, P., Sullivan, K., Franklin, M., Foa, E., Maid, R., et al. (2002). Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? Journal of Child and Adolescent Psycho­pharmacology, 12, 157–164.PubMedGoogle Scholar
  41. Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., et al. (2002). Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proceedings of the National Academy of Sciences of the United States of America, 99, 6370–6375.PubMedGoogle Scholar
  42. Guerrero, A. P., Hishinuma, E. S., Andrade, N. N., Bell, C. K., Kurahara, D. K., Lee, T. G., et al. (2003). Demographic and clinical characteristics of adolescents in Hawaii with obsessive-compulsive disorder. Archives of Pediatrics & Adolescent Medicine, 157, 665–670.Google Scholar
  43. Gustafsson, P. E., Gustafsson, P. A., Ivarsson, T., & Nelson, N. (2008). Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology, 57, 14–21.PubMedGoogle Scholar
  44. Hallett, J. J., Harling-Berg, C. J., Knopf, P. M., Stopa, E. G., & Kiessling, L. S. (2000). Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. Journal of Neuroimmunology, 111, 195–202.PubMedGoogle Scholar
  45. Hamburger, S. D., Swedo, S., Whitaker, A., Davies, M., & Rapoport, J. L. (1989). Growth rate in adolescents with obsessive-compulsive disorder. The American Journal of Psychiatry, 146, 652–655.PubMedGoogle Scholar
  46. Hamilton, C. S., Garvey, M. A., & Swedo, S. E. (2003). Sensitivity of the D8/17 assay. The American Journal of Psychiatry, 160(6), 1193–1194.PubMedGoogle Scholar
  47. Hauger, R. L., Risbrough, V., Brauns, O., & Dautzenberg, F. M. (2006). Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS & Neurological Disorders Drug Targets, 5, 453–479.Google Scholar
  48. Heubi, C., & Shott, S. R. (2003). PANDAS: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections – an uncommon, but important indication for tonsillectomy. International Journal of Pediatric Otorhinolaryngology, 67, 837–840.PubMedGoogle Scholar
  49. Hirschtritt, M. E., Hammond, C. J., Luckenbaugh, D., Buhle, J., Thurm, A. E., Casey, B. J., et al. (2009). Executive and attention functioning among children in the PANDAS subgroup. Child Neuropsychology, 15, 179–194.PubMedGoogle Scholar
  50. Hoekstra, P. J., Bijzet, J., Limburg, P. C., Steenhuis, M. P., Troost, P. W., Oosterhoff, M. D., et al. (2001). Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients. The American Journal of Psychiatry, 158(4), 605–610.PubMedGoogle Scholar
  51. Hoekstra, P. J., Horst, G., Limburg, P. C., Troost, P. W., van Lang, N., de Bildt, A., et al. (2003). Increased seroreactivity in tic disorder patients to a 60 kDa protein band from a neuronal cell line. Journal of Neuroimmunology, 141, 118–124.PubMedGoogle Scholar
  52. Hoekstra, P. J., Manson, W. L., Steenhuis, M. P., Kallenberg, C. G., & Minderaa, R. B. (2005). Association of common cold with exacerbations in pediatric but not adult patients with tic disorder: A prospective longitudinal study. Journal of Child and Adolescent Psychopharmacology, 15, 285–292.PubMedGoogle Scholar
  53. Hoekstra, P. J., Minderaa, R. B., & Kallenberg, C. G. (2004). Lack of effect of intravenous immunoglobulins on tics: A double-blind placebo-controlled study. The Journal of Clinical Psychiatry, 65, 537–542.PubMedGoogle Scholar
  54. Hoffman, K. L., Hornig, M., Yaddanapudi, K., Jabado, O., & Lipkin, W. I. (2004). A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. The Journal of Neuroscience, 24, 1780–1791.PubMedGoogle Scholar
  55. Huang, Y., Li, T., Wang, Y., Ansar, J., Lanting, G., Liu, X., et al. (2004). Linkage disequilibrium analysis of polymorphisms in the gene for myelin oligodendrocyte glycoprotein in Tourette’s syndrome patients from a Chinese sample. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 124, 76–80.Google Scholar
  56. Husby, G., van de Rijn, I., Zabriskie, J. B., Abdin, Z. H., & Williams, R. C., Jr. (1976). Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. The Journal of Experimental Medicine, 144, 1094–1110.PubMedGoogle Scholar
  57. Inoff-Germain, G., Rodriguez, R. S., Torres-Alcantara, S., Diaz-Jimenez, M. J., Swedo, S. E., & Rapoport, J. L. (2003). An immunological marker (D8/17) associated with rheumatic fever as a predictor of childhood psychiatric disorders in a community sample. Journal of Child Psychology and Psychiatry, 44(5), 782–790.PubMedGoogle Scholar
  58. Jenike, M. A., Baer, L., Brotman, A. W., Goff, D. C., Minichiello, W. E., & Regan, N. J. (1987). Obsessive-compulsive disorder, depression, and the dexamethasone suppression test. Journal of Clinical Psycho-pharmacology, 7, 182–184.PubMedGoogle Scholar
  59. Jung, M. H., Huh, M. J., Kang, D. H., Choi, J. S., Jung, W. H., Jang, J. H., et al. (2009). Volumetric differences in the pituitary between drug-naive and medicated male patients with obsessive-compulsive disorder. Progress in Neuropsychopharmacology & Biological Psychiatry, 33, 605–609.Google Scholar
  60. Kansy, J. W., Katsovich, L., McIver, K. S., Pick, J., Zabriskie, J. B., Lombroso, P. J., et al. (2006). Identification of pyruvate kinase as an antigen associated with Tourette syndrome. Journal of Neuro­immunology, 181(1–2), 165–176.PubMedGoogle Scholar
  61. Kantor, L., Hewlett, G. H., & Gnegy, M. E. (1999). Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: Differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. The Journal of Neuroscience, 19, 3801–3808.PubMedGoogle Scholar
  62. Kaplan, E. L., Rothermel, C. D., & Johnson, D. R. (1998). Antistreptolysin O and anti-deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the United States. Pediatrics, 101(1 Pt 1), 86–88.PubMedGoogle Scholar
  63. Kawikova, I., Leckman, J. F., Kronig, H., Katsovich, L., Bessen, D. E., Ghebremichael, M., et al. (2006). Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: A preliminary study. Biological Psychiatry, 61, 273–278.PubMedGoogle Scholar
  64. Kawikova, I., Leckman, J. F., Kronig, H., Katsovich, L., Bessen, D. E., Ghebremichael, M., et al. (2007). Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biological Psychiatry, 61(3), 273–278.PubMedGoogle Scholar
  65. Khanna, S., Ravi, V., Shenoy, P. K., Chandramuki, A., & Channabasavanna, S. M. (1997). Cerebrospinal fluid viral antibodies in obsessive-compulsive disorder in an Indian population. Biological Psychiatry, 41, 883–890.PubMedGoogle Scholar
  66. Kiessling, L. S., Marcotte, A. C., & Culpepper, L. (1993). Antineuronal antibodies in movement disorders. Pediatrics, 92, 39–43.PubMedGoogle Scholar
  67. Kiessling, L. S., Marcotte, A. C., & Culpepper, L. (1994). Antineuronal antibodies: Tics and obsessive-compulsive symptoms. Journal of Developmental and Behavioral Pediatrics, 15, 421–425.PubMedGoogle Scholar
  68. Kirvan, C. A., Swedo, S. E., Heuser, J. S., & Cunningham, M. W. (2003). Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Natural Medicines, 9, 914–920.Google Scholar
  69. Kirvan, C. A., Swedo, S. E., Kurahara, D., & Cunningham, M. W. (2006). Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s chorea. Autoimmunity, 39, 21–29.PubMedGoogle Scholar
  70. Kirvan, C. A., Swedo, S. E., Snider, L. A., & Cunningham, M. W. (2006). Antibody-mediated neuronal cell signaling in behavior and movement disorders. Journal of Neuroimmunology, 179, 173–179.PubMedGoogle Scholar
  71. Kluge, M., Schussler, P., Kunzel, H. E., Dresler, M., Yassouridis, A., & Steiger, A. (2007). Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. Journal of Psychiatric Research, 41, 928–933.PubMedGoogle Scholar
  72. Konturek, J. W. (2003). Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer. Journal of Physiology and Pharmacology, 54(Suppl 3), 23–41.PubMedGoogle Scholar
  73. Korn-Lubetzki, I., Brand, A., & Steiner, I. (2004). Recurrence of Sydenham chorea: Implications for pathogenesis. Archives of Neurology, 61, 1261–1264.PubMedGoogle Scholar
  74. Kotby, A. A., el Badawy, N., el Sokkary, S., Moawad, H., & el Shawarby, M. (1998). Antineuronal antibodies in rheumatic chorea. Clinical and Diagnostic Laboratory Immunology, 5, 836–839.PubMedGoogle Scholar
  75. Krause, R. M. (2002). A half-century of streptococcal research: Then & now. The Indian Journal of Medical Research, 115, 215–241.PubMedGoogle Scholar
  76. Kruesi, M. J., Swedo, S., Leonard, H., Rubinow, D. R., & Rapoport, J. L. (1990). CSF somatostatin in childhood psychiatric disorders: A preliminary investigation. Psychiatry Research, 33, 277–284.PubMedGoogle Scholar
  77. Kubera, M., Lin, A. H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001). Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. Journal of Clinical Psychopharmacology, 21, 199–206.PubMedGoogle Scholar
  78. Kuelz, A. K., Hohagen, F., & Voderholzer, U. (2004). Neuropsychological performance in obsessive-compulsive disorder: A critical review. Biological Psychology, 65, 185–236.PubMedGoogle Scholar
  79. Kurlan, R., Johnson, D., & Kaplan, E. L. (2008). Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study. Pediatrics, 121, 1188–1197.PubMedGoogle Scholar
  80. Kurlan, R., & Kaplan, E. L. (2004). The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: Hypothesis or entity? Practical considerations for the clinician. Pediatrics, 113, 883–886.PubMedGoogle Scholar
  81. Kushner, H. I., & Kiessling, L. S. (1996). The controversy over the classification of Gilles de la Tourette’s syndrome, 1800-1995. Perspectives in Biology and Medicine, 39, 409–435.PubMedGoogle Scholar
  82. Langlois, M., & Force, L. (1965). Nosologic and clinical revision of Gilles de la Tourette disease evoked by the action of certain neuroloeptics on its course. Revue Neurologique (Paris), 113, 641–645.Google Scholar
  83. Leckman, J. F., Katsovich, L., Kawikova, I., Lin, H., Zhang, H., Kronig, H., et al. (2005). Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome. Biological Psychiatry, 57, 667–673.PubMedGoogle Scholar
  84. Lieberman, J. A., Kane, J. M., Sarantakos, S., Cole, K., Howard, A., Borenstein, M., et al. (1985). Dexamethasone suppression tests in patients with obsessive-compulsive disorder. The American Journal of Psychiatry, 142, 747–751.PubMedGoogle Scholar
  85. Loiselle, C. R., Lee, O., Moran, T. H., & Singer, H. S. (2004). Striatal microinfusion of Tourette syndrome and PANDAS sera: Failure to induce behavioral changes. Movement Disorders, 19, 390–396.PubMedGoogle Scholar
  86. Lougee, L., Perlmutter, S. J., Nicolson, R., Garvey, M. A., & Swedo, S. E. (2000). Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1120–1126.PubMedGoogle Scholar
  87. Luo, F., Leckman, J. F., Katsovich, L., Findley, D., Grantz, H., Tucker, D. M., et al. (2004). Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: Relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics, 113, e578–585.PubMedGoogle Scholar
  88. Martino, D., Church, A. J., Dale, R. C., & Giovannoni, G. (2005). Antibasal ganglia antibodies and PANDAS. Movement Disorders, 20, 116–117.PubMedGoogle Scholar
  89. Matsuo, M., Tsuchiya, K., Hamasaki, Y., & Singer, H. S. (2004). Restless legs syndrome: Association with streptococcal or mycoplasma infection. Pediatric Neurology, 31, 119–121.PubMedGoogle Scholar
  90. McCracken, J. T., & Hanna, G. L. (2005). Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: Effects of clomipramine treatment. Journal of Child and Adolescent Psychopharmacology, 15, 581–587.PubMedGoogle Scholar
  91. McDonald, M. I., Towers, R. J., Andrews, R. M., Benger, N., Currie, B. J., & Carapetis, J. R. (2006). Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clinical Infectious Diseases, 43, 683–689.PubMedGoogle Scholar
  92. Mell, L. K., Davis, R. L., & Owens, D. (2005). Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics, 116, 56–60.PubMedGoogle Scholar
  93. Mercadante, M. T., Busatto, G. F., Lombroso, P. J., Prado, L., Rosario-Campos, M. C., do Valle, R., et al. (2000). The psychiatric symptoms of rheumatic fever. The American Journal of Psychiatry, 157, 2036–2038.PubMedGoogle Scholar
  94. Miettinen, M., Matikainen, S., Vuopio-Varkila, J., Pirhonen, J., Varkila, K., Kurimoto, M., et al. (1998). Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infection and Immunity, 66, 6058–6062.PubMedGoogle Scholar
  95. Monteleone, P., Catapano, F., Fabrazzo, M., Tortorella, A., & Maj, M. (1998). Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology, 37, 182–185.PubMedGoogle Scholar
  96. Morer, A., Lazaro, L., Sabater, L., Massana, J., Castro, J., & Graus, F. (2006). Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. Journal of Psychiatric Research, 42, 64–68.PubMedGoogle Scholar
  97. Morer, A., Vinas, O., Lazaro, L., Bosch, J., Toro, J., & Castro, J. (2005). D8/17 monoclonal antibody: An unclear neuropsychiatric marker. Behavioural Neurology, 16, 1–8.PubMedGoogle Scholar
  98. Morshed, S. A., Parveen, S., Leckman, J. F., Mercadante, M. T., Bittencourt Kiss, M. H., Miguel, E. C., et al. (2001). Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette’s syndrome, Sydenham’s chorea, and autoimmune disorders. Biological Psychiatry, 50, 566–577.PubMedGoogle Scholar
  99. Muller, N., Kroll, B., Schwarz, M. J., Riedel, M., Straube, A., Lutticken, R., et al. (2001). Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette’s syndrome. Psychiatry Research, 101, 187–193.PubMedGoogle Scholar
  100. Muller, N., Riedel, M., Blendinger, C., Oberle, K., Jacobs, E., & Abele-Horn, M. (2004). Mycoplasma pneumoniae infection and Tourette’s syndrome. Psychiatry Research, 129, 119–125.PubMedGoogle Scholar
  101. Muller, N., Riedel, M., Forderreuther, S., Blendinger, C., & Abele-Horn, M. (2000). Tourette’s syndrome and mycoplasma pneumoniae infection. The American Journal of Psychiatry, 157, 481–482.PubMedGoogle Scholar
  102. Murphy, T. K., Goodman, W. K., Fudge, M. W., Williams, R. C., Ayoub, E. M., Dalal, M., et al. (1997). B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette’s syndrome? The American Journal of Psychiatry, 154(3), 402–407.PubMedGoogle Scholar
  103. Murphy, T. K., Benson, N., Zaytoun, A., Yang, M., Braylan, R., Ayoub, E., et al. (2001). Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. Journal of Neuroimmunology, 120(1–2), 146–151.PubMedGoogle Scholar
  104. Murphy, M. L., & Pichichero, M. E. (2002). Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Archives of Pediatrics & Adolescent Medicine, 156, 356–361.Google Scholar
  105. Murphy, T. K., Sajid, M., Soto, O., Shapira, N., Edge, P., Yang, M., et al. (2004). Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biological Psychiatry, 55, 61–68.PubMedGoogle Scholar
  106. Murphy, T. K., Snider, L. A., Mutch, P. J., Harden, E., Zaytoun, A., Edge, P. J., et al. (2006). Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biological Psychiatry, 61, 279–284.PubMedGoogle Scholar
  107. Murr, C., Gerlach, D., Widner, B., Dierich, M. P., & Fuchs, D. (2001). Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes. Medical Microbiology and Immunology (Berlin), 189, 161–163.Google Scholar
  108. Nicolson, R., Swedo, S. E., Lenane, M., Bedwell, J., Wudarsky, M., Gochman, P., et al. (2000). An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1313–1315.PubMedGoogle Scholar
  109. Orvidas, L. J., & Slattery, M. J. (2001). Pediatric autoimmune neuropsychiatric disorders and streptococcal infections: Role of otolaryngologist. The Laryngoscope, 111, 1515–1519.PubMedGoogle Scholar
  110. Pacher, P., & Kecskemeti, V. (2004). Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Current Medicinal Chemistry, 11, 925–943.PubMedGoogle Scholar
  111. Paluck, E., Katzenstein, D., Frankish, C. J., Herbert, C. P., Milner, R., Speert, D., et al. (2001). Prescribing practices and attitudes toward giving children antibiotics. Canadian Family Physician, 47, 521–527.PubMedGoogle Scholar
  112. Pavone, P., Bianchini, R., Parano, E., Incorpora, G., Rizzo, R., Mazzone, L., et al. (2004). Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatric Neurology, 30, 107–110.PubMedGoogle Scholar
  113. Perlmutter, S. J., Leitman, S. F., Garvey, M. A., Hamburger, S., Feldman, E., Leonard, H. L., et al. (1999). Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet, 354, 1153–1158.PubMedGoogle Scholar
  114. Perrin, E. M., Murphy, M. L., Casey, J. R., Pichichero, M. E., Runyan, D. K., Miller, W. C., et al. (2004). Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Archives of Pediatrics & Adolescent Medicine, 158, 848–856.Google Scholar
  115. Peterson, B. S., Leckman, J. F., Tucker, D., Scahill, L., Staib, L., Zhang, H., et al. (2000). Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Archives of General Psychiatry, 57, 364–372.PubMedGoogle Scholar
  116. Pichichero, M. E. (2009). The PANDAS syndrome. Advances in Experimental Medicine and Biology, 634, 205–216.PubMedGoogle Scholar
  117. Pine, D. S., Cohen, P., & Brook, J. (1996). Emotional problems during youth as predictors of stature during early adulthood: Results from a prospective epidemiologic study. Pediatrics, 97(6 Pt 1), 856–863.PubMedGoogle Scholar
  118. Pittenger, C., Krystal, J. H., & Coric, V. (2006). Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx, 3, 69–81.PubMedGoogle Scholar
  119. Puxley, F., Midtsund, M., Iosif, A., & Lask, B. (2008). PANDAS anorexia nervosa – endangered, extinct or nonexistent? The International Journal of Eating Disorders, 41, 15–21.PubMedGoogle Scholar
  120. Ravindran, A. V., Griffiths, J., Merali, Z., & Anisman, H. (1999). Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. Journal of Affective Disorders, 52, 1–10.PubMedGoogle Scholar
  121. Read, S. E., Reid, H. F., Fischetti, V. A., Poon-King, T., Ramkissoon, R., McDowell, M., et al. (1986). Serial studies on the cellular immune response to streptococcal antigens in acute and convalescent rheumatic fever patients in Trinidad. Journal of Clinical Immunology, 6, 433–441.PubMedGoogle Scholar
  122. Renneberg, J., Soderstrom, M., Prellner, K., Forsgren, A., & Christensen, P. (1989). Age-related variations in anti-streptococcal antibody levels. European Journal of Clinical Microbiology & Infectious Diseases, 8, 792–795.Google Scholar
  123. Risbrough, V. B., & Stein, M. B. (2006). Role of corticotropin releasing factor in anxiety disorders: A translational research perspective. Hormones and Behavior, 50, 550–561.PubMedGoogle Scholar
  124. Rizzo, R., Gulisano, M., Pavone, P., Fogliani, F., & Robertson, M. M. (2006). Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: Controlled cross-sectional study. Journal of Child Neurology, 21, 747–753.PubMedGoogle Scholar
  125. Roberts-Lewis, J. M., Welsh, M. J., & Gnegy, M. E. (1986). Chronic amphetamine treatment increases striatal calmodulin in rats. Brain Research, 384, 383–386.PubMedGoogle Scholar
  126. Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., et al. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature, 433, 73–77.PubMedGoogle Scholar
  127. Roy, B. F., Benkelfat, C., Hill, J. L., Pierce, P. F., Dauphin, M. M., Kelly, T. M., et al. (1994). Serum antibody for somatostatin-14 and prodynorphin 209-240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer’s disease, multiple sclerosis, and advanced HIV infection. Biological Psychiatry, 35, 335–344.PubMedGoogle Scholar
  128. Sabharwal, H., Michon, F., Nelson, D., Dong, W., Fuchs, K., Manjarrez, R. C., et al. (2006). Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection. The Journal of Infectious Diseases, 193, 129–135.PubMedGoogle Scholar
  129. Sanchez-Carpintero, R., Albesa, S. A., Crespo, N., Villoslada, P., & Narbona, J. (2009). A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder. Journal of Neurology, 256, 1103–1108.PubMedGoogle Scholar
  130. Schrag, A., Gilbert, R., Giovannoni, G., Robertson, M. M., Metcalfe, C., & Ben-Shlomo, Y. (2009). Streptococcal infection, Tourette syndrome, and OCD: Is there a connection? Neurology, 73, 1256–1263.PubMedGoogle Scholar
  131. Segarra, A. R., & Murphy, T. K. (2008). Cardiac involvement in children with PANDAS. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 603–604.PubMedGoogle Scholar
  132. Sela, S., Neeman, R., Keller, N., & Barzilai, A. (2000). Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells. Journal of Medical Microbiology, 49, 499–502.PubMedGoogle Scholar
  133. Selling, L. (1929). The role of infection in the etiology of tics. Archives of Neurology and Psychiatry, 22, 1163–1171.Google Scholar
  134. Shet, A., & Kaplan, E. L. (2002). Clinical use and interpretation of group A streptococcal antibody tests: A practical approach for the pediatrician or primary care physician. The Pediatric Infectious Disease Journal, 21, 420–426; quiz 427–430.Google Scholar
  135. Singer, H. S., Gause, C., Morris, C., & Lopez, P. (2008). Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics, 121, 1198–1205.PubMedGoogle Scholar
  136. Singer, H. S., Giuliano, J. D., Hansen, B. H., Hallett, J. J., Laurino, J. P., Benson, M., et al. (1998). Antibodies against human putamen in children with Tourette syndrome. Neurology, 50, 1618–1624.PubMedGoogle Scholar
  137. Singer, H. S., Giuliano, J. D., Zimmerman, A. M., & Walkup, J. T. (2000). Infection: A stimulus for tic disorders. Pediatric Neurology, 22, 380–383.PubMedGoogle Scholar
  138. Singer, H. S., Hong, J. J., Yoon, D. Y., & Williams, P. N. (2005). Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology, 65, 1701–1707.PubMedGoogle Scholar
  139. Singer, H. S., Mink, J. W., Loiselle, C. R., Burke, K. A., Ruchkina, I., Morshed, S., et al. (2005). Microinfusion of antineuronal antibodies into rodent striatum: Failure to differentiate between elevated and low titers. Journal of Neuroimmunology, 163, 8–14.PubMedGoogle Scholar
  140. Snider, L. A., Lougee, L., Slattery, M., Grant, P., & Swedo, S. E. (2005). Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biological Psychiatry, 57, 788–792.PubMedGoogle Scholar
  141. Snider, L. A., Sachdev, V., MaCkaronis, J. E., St Peter, M., & Swedo, S. E. (2004). Echocardiographic findings in the PANDAS subgroup. Pediatrics, 114, e748–751.PubMedGoogle Scholar
  142. Sokol, M. S. (2000). Infection-triggered anorexia nervosa in children: Clinical description of four cases. Journal of Child and Adolescent Psychopharmacology, 10, 133–145.PubMedGoogle Scholar
  143. Stahl, S. M. (2008). The sigma enigma: Can sigma receptors provide a novel target for disorders of mood and cognition? The Journal of Clinical Psychiatry, 69, 1673–1674.PubMedGoogle Scholar
  144. Suerbaum, S., & Michetti, P. (2002). Helicobacter pylori infection. The New England Journal of Medicine, 347, 1175–1186.PubMedGoogle Scholar
  145. Swedo, S. E., & Leonard, H. L. (1994). Childhood movement disorders and obsessive compulsive disorder. The Journal of Clinical Psychiatry, 55(Suppl), 32–37.PubMedGoogle Scholar
  146. Swedo, S. E., Leonard, H. L., Mittleman, B. B., Allen, A. J., Rapoport, J. L., Dow, S. P., et al. (1997). Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. The American Journal of Psychiatry, 154(1), 110–112.PubMedGoogle Scholar
  147. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., et al. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. The American Journal of Psychiatry, 155, 264–271.PubMedGoogle Scholar
  148. Tait, A. S., Butts, C. L., & Sternberg, E. M. (2008). The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. Journal of Leukocyte Biology, 84, 924–931.PubMedGoogle Scholar
  149. Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimizu, T. A., et al. (2004). The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. The Journal of Clinical Investigation, 113, 302–309.PubMedGoogle Scholar
  150. Taylor, J. R., Morshed, S. A., Parveen, S., Mercadante, M. T., Scahill, L., Peterson, B. S., et al. (2002). An animal model of Tourette’s syndrome. The American Journal of Psychiatry, 159, 657–660.PubMedGoogle Scholar
  151. Terreri, M. T., Roja, S. C., Len, C. A., Faustino, P. C., Roberto, A. M., & Hilario, M. O. (2002). Sydenham’s chorea – clinical and evolutive characteristics. São Paulo Medical Journal, 120, 16–19.PubMedGoogle Scholar
  152. Thomsen, P. H., & Mikkelsen, H. U. (1995). Course of obsessive-compulsive disorder in children and adolescents: A prospective follow-up study of 23 Danish cases. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1432–1440.PubMedGoogle Scholar
  153. Weisz, J. L., McMahon, W. M., Moore, J. C., Augustine, N. H., Bohnsack, J. F., Bale, J. F., et al. (2004). D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette’s disorder. Clinical and Diagnostic Laboratory Immunology, 11(2), 330–336.PubMedGoogle Scholar
  154. Zai, G., Bezchlibnyk, Y. B., Richter, M. A., Arnold, P., Burroughs, E., Barr, C. L., et al. (2004). Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 129, 64–68.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of PsychiatryUniversity of South FloridaSt. PetersburgUSA

Personalised recommendations